Format

Send to

Choose Destination
BMC Genomics. 2017 Aug 11;18(Suppl 5):550. doi: 10.1186/s12864-017-3913-1.

Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine.

Author information

1
School of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, UK.
2
Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK.
3
Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK. Kay.Thomas@gstt.nhs.uk.
4
School of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ, UK. m.n.wass@kent.ac.uk.

Abstract

BACKGROUND:

Cystinuria is an inherited disease that results in the formation of cystine stones in the kidney, which can have serious health complications. Two genes (SLC7A9 and SLC3A1) that form an amino acid transporter are known to be responsible for the disease. Variants that cause the disease disrupt amino acid transport across the cell membrane, leading to the build-up of relatively insoluble cystine, resulting in formation of stones. Assessing the effects of each mutation is critical in order to provide tailored treatment options for patients. We used various computational methods to assess the effects of cystinuria associated mutations, utilising information on protein function, evolutionary conservation and natural population variation of the two genes. We also analysed the ability of some methods to predict the phenotypes of individuals with cystinuria, based on their genotypes, and compared this to clinical data.

RESULTS:

Using a literature search, we collated a set of 94 SLC3A1 and 58 SLC7A9 point mutations known to be associated with cystinuria. There are differences in sequence location, evolutionary conservation, allele frequency, and predicted effect on protein function between these mutations and other genetic variants of the same genes that occur in a large population. Structural analysis considered how these mutations might lead to cystinuria. For SLC7A9, many mutations swap hydrophobic amino acids for charged amino acids or vice versa, while others affect known functional sites. For SLC3A1, functional information is currently insufficient to make confident predictions but mutations often result in the loss of hydrogen bonds and largely appear to affect protein stability. Finally, we showed that computational predictions of mutation severity were significantly correlated with the disease phenotypes of patients from a clinical study, despite different methods disagreeing for some of their predictions.

CONCLUSIONS:

The results of this study are promising and highlight the areas of research which must now be pursued to better understand how mutations in SLC3A1 and SLC7A9 cause cystinuria. The application of our approach to a larger data set is essential, but we have shown that computational methods could play an important role in designing more effective personalised treatment options for patients with cystinuria.

KEYWORDS:

Computational predictions; Cystinuria; ExAC; Personalised medicine; Structural modelling

PMID:
28812535
PMCID:
PMC5558187
DOI:
10.1186/s12864-017-3913-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center